Third, although we initially demonstrated the important role of glutamine in prostate cancer cells through qPCR and siRNA silencing of target genes in this experiment, extensive in vivo and in vitro experiments are still needed to further explore the potential mechanisms behind the regulation of glutamine metabolism in PCa risk score and BCR. This evidence concerns the gene BCR and prostate cancer.